Monthly Archives: August 2009
U.S. Food and Drug Administration Approves Saxagliptin (Onglyza) for Type 2 Diabetes
Yesterday, July 31, 2009, the FDA approved use of saxagliptin, a DPP4 inhibitor, in adults with type 2 diabetes as an adjunct to diet and exercise. Bristol-Myers Squibb and AstraZeneca will sell the drug under the brand name Onglyza. The drug’s … Continue reading
Filed under Drugs for Diabetes
